Petra Hamerlik, who previously worked at AstraZeneca plc, has been appointed as the Chair of Translational Neuro-Oncology at the University of Manchester.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Petra Hamerlik, who previously worked at AstraZeneca plc, has been appointed as the Chair of Translational Neuro-Oncology at the University of Manchester.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
Petra Hamerlik
researcher
Nothing else this week.
-
University of Manchester
public research university in Manchester, England, United Kingdom